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Distinct gene expression patterns correlate with
developmental and functional traits of iNKTsubsets
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Invariant natural killer T (iNKT) cells comprise a subpopulation of innate lymphocytes
developing in thymus. A new model proposes subdividing murine iNKT cells into iNKT1,
2 and 17 cells. Here, we use transcriptome analyses of iNKT1, 2 and 17 subsets isolated
from BALB/c and C57BL/6 thymi to identify candidate genes that may affect iNKT cell
development, migration or function. We show that Fcer1g is involved in generation of iNKT1
cells and that SerpinB1 modulates frequency of iNKT17 cells. Moreover, a considerable
proportion of iNKT17 cells express IL-4 and IL-17 simultaneously. The results presented not
only validate the usefulness of the iNKT1/2/17-concept but also provide new insights into
iNKT cell biology.
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N
atural killer T cells can be grouped into several subtypes
of which the type I invariant natural killer T (iNKT) cells
are most vigorously investigated1. This is due to the
ease of detecting them using CD1d-tetramers loaded with
a-galactosylceramide (a-galcer) or a glycolipid derived from it.
Given the highly restricted set of TCRa,b-chains expressed
(Va14Ja18-Vb2,7,8.1/2/3 in mouse) coining the name invariant,
iNKT cells are involved in a surprisingly wide range of immune
relevant processes such as activating NK or B cell2,3 or biasing
T cell responses and activities of dendritic cells (DC)4,5.
Consequently, iNKT cells can inﬂuence the outcome of various
diseases ranging from bacterial or viral infection6,7 and cancer8 to
autoimmune and allergy syndromes9,10. These ﬁndings fostered
interest in this highly specialized T cell type that comes into
existence in the thymus when T cells pass through the double
positive stage of their differentiation11. iNKT cells differ from
regular naı¨ve T cells not only in the limited set of T cell receptors
(TCR) expressed, but also in their quasi antigen experienced
status that enables immediate reaction to TCR-mediated or
cytokine-induced stimuli by secreting a variety of cytokines12–14.
In addition, in contrast to naive T cells, iNKT cells can leave the
thymus as immature cells and complete differentiation in the
periphery15,16 with minimal recirculation17. Moreover, iNKT
cells express a variety of homing receptors licensing them to
migrate to lymphoid but also non-lymphoid organs, including
skin, liver and lung18.
Much of our insights regarding murine iNKT cells were
derived from experimentation in C57Bl/6 mice, the strain that
also served to establish the classical model subdividing iNKT cells
according to their developmental stages, S0–S3 (ref. 19).
This classiﬁcation rests in part on the marker NK1.1 deﬁning
the iNKT cell stages as follows: S0 (CD24þCD44loNK1.1lo);
S1 (CD24loCD44loNK1.1lo); S2 (CD24loCD44hiNK1.1lo);
S3 (CD24loCD44hiNK1.1hi)15,16. Differentiating iNKT cells
switch from a predominant IL-4 secretion to predominant
IFNg production, a process termed TH2 to TH1 conversion15.
However, NK1.1 is not expressed by many other mouse strains,
including BALB/c mice, thereby impeding comparability of iNKT
subtypes. Moreover, it was difﬁcult to integrate IL-17 producing
iNKT cells, discovered later, into the established concept20. iNKT
cell differentiation is governed by key transcription factors PLZF,
TBET, GATA3, THPOK and RORgt21,22 that serve as markers to
deﬁne murine iNKT subtypes23. A subdivision of iNKT cells
identiﬁed by expression of PLZF, TBET and RORgt matches
well with the secretion of key cytokines IFNg, IL-4 and IL-17,
respectively11,20,23. Following the TH1/2/17-paradigm, iNKT
cells can thus be deﬁned as PLZFloT-betþRORgt
iNKT1 (IFNgþ ), PLZFhiT-betRORgt iNKT2 (IL-4þ ) and
PLZFintT-betRORgtþ iNKT17 (IL-17þ ) cells providing a solid
platform to also discriminate iNKT cells by their functional
qualities1,11. Comparing the classical concept (S0–S3) with the
recently described classiﬁcation (iNKT1/2/17) it is evident that,
neglecting sharp borders, iNKT2 cells correspond to more
immature iNKT cells whereas iNKT1 cells represent terminally
differentiated cells. However, iNKT2 cells actively secreting IL-4
cannot give rise to the more mature iNKT1 cells23, raising
doubts of a straight-forward developmental programme
executed by differentiating iNKT cells. An alternative
differentiation pathway is that iNKT1, 2 and 17 cells
develop directly from a common precursor. Despite these
unresolved issues, the iNKT1/2/17-concept has gained quick
acceptance.
Although transcriptome analyses of iNKT cells have been
published24–26, only one study has provided new insights into
iNKT cell function and development based on the iNKT1/2/17-
classiﬁcation27. In the study presented here, we used a simple
gating strategy to investigate the transcriptomes of iNKT1, 2 and
17 cells from thymus of BALB/c and C57BL/6 mice. The results
conﬁrmed that a subdivision into iNKT1, 2 and 17 cells is suitable
to characterize iNKT cells independent of the strain but also
revealed candidate genes that may explain strain dependent
variations in iNKT subset composition reported earlier23. We
identify many genes that are expressed in a subtype speciﬁc
fashion in both strains and by investigating corresponding
mutant mice, we show that Fcer1g and serpinB1 are involved
in generating wild type (WT)-like iNKT subset compositions.
Furthermore, we investigate the importance of receptors known
to be important for migration of iNKT cells. Notably, we observe
that iNKT17 cells express IL-4 to a substantial extent indicating a
hitherto unrecognized heterogeneity in this subpopulation. Along
these lines, CD4 /lo iNKT1 cells differ from CD4þ iNKT1 cells
with respect to their NK-like phenotype. These observations
indicate that not only iNKT2 but also iNKT1 and iNKT17 subsets
are composed of at least two subpopulations. Nevertheless, in
their entity the data broadly and impressively support the
theoretical fundament of the iNKT1/2/17-concept.
Results
Transcriptome analysis of thymic iNKT subsets. iNKT1, 2 and
17 cells are usually identiﬁed by the expression pattern regarding
transcription factors that requires permeabilization of the cells.
However, Lee et al.23 showed that a combination of antibodies
recognizing CD122, CD4 and CD27 is also suitable to identify
iNKT subtypes among tetramer (tet)þ cells. We noted that
already the use of CD122 and CD4 results in an adequate
separation of tetþ gated thymocytes into iNKT1, 2 and 17 cells
(Fig. 1a,b). This is proven by their homogeneous expression of
PLZF and TBET (Fig. 1d). Next, we sorted iNKT cells of thymus
of BALB/c and C57BL/6 (B6) mice into iNKT1, 2 and 17 cells
according to the gating strategy shown in Fig. 1b. RNA was
prepared and samples processed for hybridization of Agilent
chips as described in Methods. We performed two completely
independent experiments each for BALB/c and B6 (GEO
accession number GSE69120). Except for the heat maps, we
display the results obtained as intensity data (RNA units (RU)) in
bar diagrams as means±s.d. to illustrate that both analyses, for
BALB/c as well as for B6, yielded consistent ﬁndings. Although
this suggests a high degree of reliability, it should be noted that
the low number of replicates, n¼ 2, still represents an element of
uncertainty. mRNA data reﬂecting expression of TBET (Tbx21),
PLZF (Zbtb16), and RORg,gt (Rorc) matched expectations
(Fig. 1e) and expression patterns of Ccl5, Il13 as well as Il23r
are shown as further examples to demonstrate that the cell sorts
were clean enough allowing reliable characterization of iNKT
subsets based in their transcriptional proﬁles (Fig. 1f). CCL5 is
produced by activated NK cells and among iNKT cells, iNKT1
cells resemble most NK cells (see later). IL-13 is expressed by
iNKT2 but not iNKT1 and iNKT17 cells28 and the receptor for
IL-23 is critically involved in IL-17 expression by iNKT17 cells22.
The heat map in Fig. 2a depicts a series of genes displaying
subtype speciﬁc expression. Global analysis of the chip data
reveals that within given margins (legend to Fig. 2) nearby 20,000
genes were low to not expressed in pairwise comparisons of iNKT
subtypes, whereas B10,000 genes were expressed but did not
differ substantially in expression strength (less than twofold,
Fig. 2b). Approximately 300–600 transcripts were classiﬁed
unique. Even though the vast majority of genes exhibit an
expression pattern identical or highly similar between cells of
BALB/c and B6 origin, a noticeable set of genes differ in their
expression when comparing iNKT subsets of these two mouse
strains (Fig. 2c,d; Supplementary Table 1).
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Figure 1 | Discrimination of iNKT subsets using various markers. (a) CD4 and CD122 expression discriminates iNKT1, 2 and 17 populations among
DAPICD19 thymocytes as indicated by arrows. (b) Alternative representation of iNKTpopulations of thymus of BALB/c (upper panel) and of B6 (lower
panel) using markers CD3e, CD1d-tetramer, CD4 and CD122 as in a. The numbers in a,b indicate the frequencies of the cells in the corresponding gates.
(c) iNKT1, 2 and 17 cells gated as in a expressed different levels of CD3e (left panel, surface stain) or CD247 (CD3z, right panel, permeabilized cells).
(d) iNKT subpopulations deﬁned by CD4/CD122 expression were monitored for their expression of PLZF and RORgt. Gates shown in left panel were
applied to deﬁne iNKTsubsets and to test their purity with regard to expression of PLZF and RORgt (three panels to the right). Numbers reﬂect percentage
of cells in the encircled areas. (e,f) mRNA expression proﬁles resulting from chip-based transcriptome analysis as described in the text. RU represents an
arbitrary deﬁnition of expression strength. Open bars: values for BALB/c cells, scale to the left; black bars: values for B6, scale to the right. Shown are
means±s.d. Data are representative of at least 5 (a), 5 (b), 5 (c, left panel), 2 (c, right panel) and 2 (d) experiments. Data shown in e,f are from two
independently performed transcriptome analyses each, BALB/c and B6. Shown are mean±s.d. (n¼ 2).
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Expression of the TCR complex characterizes iNKT subtypes.
Interestingly, apart from CD4 (ref. 29), marked iNKT subtype
speciﬁc variations exist in the expression of several genes
implicated in TCR signalling. mRNAs coding for CD3e but also
CD3d and CD3g are highly and equally well expressed among all
iNKT subsets (Fig. 3a). However, when dissecting iNKT sub-
populations as shown in Fig. 1a (right panel), it is clear that their
CD3e/TCR-expression is different in strength depending on the
iNKT subtype (Fig. 1c, left panel). Therefore, in case of CD3e the
amount of mRNA expressed doesn’t correspond to the level of
protein detected on the surface of the cells. In contrast, the
mRNA signal intensity for the CD3z chain (CD247) (Fig. 3b)
varies greatly depending on the iNKT subtype and its expression
levels mirrors the amount of TCR or CD3e detected on the
surface of the corresponding iNKT cell subtypes (Fig. 1c, right
panel). This observation suggests that the CD3z chain is an
important determinant governing levels of TCR surface
expression30 thereby inﬂuencing the strength of the TCR signal.
Interestingly, the low expression of CD3z in iNKT1 cells
coincides with a strong mRNA signal for the FceR1g chain
(Fig. 3b) that is part of the high-afﬁnity receptor for IgE and can
also pair with the CD3z chain in the NCR1 signalling adaptor31
as well as the TCR complex32,33. This modiﬁed complex is likely
to trigger altered TCR signalling34. Indeed, in thymus of BALB/
cByJ mice deﬁcient for the FceR1g chain iNKT cells are reduced
in frequency but not number as compared with WT (Fig. 3c,
please note that the strain BALB/cByJ differs from the commonly
used strain BALB/c). More precisely, iNKT1 cell frequency and
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Figure 2 | Evaluation and summary of transcriptome data. (a,c) Heat maps representing expression of the genes listed to the right. Data source
as in Fig. 1e,f (n¼ 2). (b) Venn diagrams resulting from pairwise comparisons of iNKT subsets. To generate the Venn diagrams, expression levels below
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analyses as depicted in Fig. 1e,f (mean±s.d., n¼ 2). Shown are three selected genes that exhibited a mouse strain speciﬁc pattern: Ctsl (cathepsin L),
Hey1 (HESR1) and Ascl1 (MASH1).
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number are lower compared with WT controls whereas those of
iNTK2 increase. In periphery, differences regarding composition
of iNKT subtypes are not evident (spleen) or much less
pronounced (liver) when comparing knock-out and WT
animals although overall frequency of iNKT cells is decreased
in spleen (Supplementary Fig. 1a,b). Most likely, not only does
this phenomenon reﬂects the well-known capacity of peripheral
iNKT cells to propagate and differentiate but also indicates that
the maturation pathways or kinetics in thymus differ from those
in periphery35. These results were conﬁrmed when iNKT subsets
were identiﬁed based on their expression of PLZF and RORgt
(Supplementary Fig. 1c,d). Moreover, the chip data reveal a high
and very speciﬁc expression of the B lymphoid tyrosine kinase
(Blk) in iNKT17 cells which is involved in signalling via surface
bound BCR on B cells (Fig. 3b). Although not being part of the
TCR complex, BLK inﬂuences TCR signalling in gdT cells and it
is crucially involved in development of gdT effector cells
producing IL-17 (ref. 36). Thus, each subset of iNKT cells may
have developed unique TCR-signalling features suitable to
support their specialized effector functions and probably also
their differentiation.
iNKT17 cells can express IL-4 along with IL-17. With respect
to the key cytokines, IFNg is strongly expressed in iNKT1 cells
and IL-17 mRNA is only detectable in iNKT17 cells (Fig. 4a).
Note that the signal intensity is low wherefore the bars visible for
b
a
Cd247 BlkFcer1g
Cd3e Cd3d Cd3g
0 0
5
10
15
10
15
20
5
0 0
5
10
15
20
30
50
10
40
0 0
3
6
9
12
15
10
20
30
40
NKT1 NKT2 NKT17
NKT1 NKT2 NKT17 NKT1 NKT2 NKT17 NKT1 NKT2 NKT17
NKT1 NKT2 NKT17 NKT1 NKT2 NKT17
0 0
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
1,0
00
)
R
N
A 
un
its
 (×
1,0
00
)
R
N
A 
un
its
 (×
1,0
00
)
R
N
A 
un
its
 (×
1,0
00
)
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
10
,00
0)
R
N
A 
un
its
 (×
10
,00
0)
10
15
20
5
10
15
20
5
0 0
20
30
40
10
20
30
40
10
0 0
20
30
40
10
20
30
40
10
BALBc
B6
BALBc
B6
c
CD
12
2
CD4
21.5
40.5
Thymus
Gated on tet+
0
N
KT
1 
ce
lls
 (%
)
0
10
20
30
N
KT
17
 c
el
ls
 (%
)
0
20
40
80
N
KT
2 
ce
lls
 (%
)
NS***
20
40
100
60
80 60
***
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
Fce
R1g
–
/–
WT
0
N
KT
 c
el
ls
 (%
)
***
1
2
BALBc ByJ
WT
BALBc ByJ
FceR1g–/–
36.8
22.6
70.3
8.2
N
KT
1 
ce
lls
 
N
KT
17
 c
el
ls
N
KT
2 
ce
lls
NS** **
N
KT
 c
el
ls
107
106
105
104
107
106
105
104
107
106
105
104
107
106
105
104
NS
Figure 3 | Expression of genes modulating TCR-mediated signalling. (a,b) Expression of the indicated genes in the iNKT subsets depicted as in
Fig. 1e,f (mean±s.d., n¼ 2). (c) iNKT cells (DAPIB220 tetþ ) were gated as shown in the left panels to determine iNKT subtype composition
(panels to the right). The data shown in the left two panels of c are representative of at least ﬁve individually stained thymi. Data shown in the right panels
of c were collected from two independent experiments. Each dot represents one animal (WT: n¼8, ko: n¼ 5). Unpaired two-tailed t-test was performed.
NS, not signiﬁcant (P40.05), **Po0.01 ***Po0.001.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13116 ARTICLE
NATURE COMMUNICATIONS | 7:13116 | DOI: 10.1038/ncomms13116 | www.nature.com/naturecommunications 5
iNKT1 and iNKT2 cells represent background intensity and not
bona ﬁde signals. mRNA coding for IL-4 is not only present in
iNKT2 cells but also in iNKT17 to a low yet signiﬁcant extent
rendering it unlikely that cross-contaminating iNKT2 were
causing it. Since it is known that some iNKT cells express both,
IL-4 and IFNg, at the same time37,38, we applied a protocol
allowing the simultaneous detection by ﬂow cytometry of the
three key cytokines IFNg, IL-4 and IL-17 in PMA/ionomycin
stimulated iNKT cells sorted from BALB/c and B6 thymi
(Fig. 4b). The cytokine expression proﬁles of BALB/c iNKT
cells differ profoundly from B6 cells but much of these differences
are caused by the very different subset composition of the thymic
iNKT cells (Supplementary Fig. 2b,c). For example, iNKT1 cells
producing IFNg prevail in B6 and therefore IFNgþ cells are more
frequent when compared with BALB/c (Fig. 4b). Cells of both
strains have in common subpopulations expressing either
cytokine alone as well as cells expressing IL-4 along with IFNg
but also cells expressing IL-4 and IL-17 simultaneously. Notably,
cells expressing IFNg and IL-17 are extremely rare in both,
BALB/c and B6 thymus. To investigate more thoroughly the
subtype origin of the cytokine single or double producing cells,
iNKT cells sorted into iNKT1, 2 and 17 subpopulations (Fig. 1b)
were stimulated with PMA/ionomycin and their cytokine
expression proﬁle assessed by ﬂow cytometry (Fig. 4c). As
expected, BALB/c iNKT1 cells produce IFNg to a large extent and
roughly 10% of these cells are IFNgþ IL-4þ . Approximately 50%
of BALB/c iNKT2 cells produce IL-4 and about 10% of these
are IL-4þ IL-17lo-hi. The IL-17 signal of these cells is not
homogeneous but scatters along the IL-17 axis. A considerable
percentage of iNKT2 cells are IFNgþ IL-4þ . Approximately
b
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70–80% of BALB/c iNKT17 cells are IL-17þ but roughly half of
these cells also produce IL-4 although the signal intensity of the
IL-4 signal among the double producers is lower than that
observed in the iNKT2 IL-4þ IL-17lo-hi cells. The quite different
appearance of the cytokine double producers, IL-4þ IL-17lo-hi
versus IL-4loIL-17þ , present among iNKT2, and iNKT17 cells,
respectively, makes it unlikely that they originated from mutual
cross-contamination during iNKT sorts but rather identiﬁes them
as separate constituents of the iNKT2 and iNKT17 cell pool. This
is supported by the observation that BALB/c iNKT2 cells
expressing IL-17 are RORgt whereas all other IL-17þ iNKT
cells (presumably iNKT17 cells) express RORgt (Supplementary
Fig. 3a). The pronounced simultaneous production particularly of
IL-4 and IL-17 by iNKT17 cells reported here may be provoked
by the massive and somewhat artiﬁcial PMA/ionomycin
stimulation. Therefore, sorted iNKT17 cells from BALB/c
thymus were stimulated in vitro with anti CD3/CD28 antibody
to mimic a more physiological setting. Expectedly, this results in a
less robust cytokine production but also under these conditions,
a population of IL-4loIL-17þ cells is clearly detectable
(Supplementary Fig. 3b). iNKT subpopulations sorted from B6
thymus show on PMA/ionomycin stimulation cytokine
expression proﬁles that are similar to those obtained from the
BALB/c cells although variations exist regarding the frequency of
distinct cytokine expressing cells. However, the purity of sorted
iNKT17 cells is lower than in case of BALB/c probably because
the preponderance of iNKT1 cells present among B6 tetþ cells
results in a certain degree of contamination during the sort.
Neglecting these technical limitations, also in B6 it is evident that
iNKT17 cells are composed of IL-17þ and IL-4loIl-17þ cells.
Moreover, iNKT2 cells encompass a small but signiﬁcant fraction
of IL-4þ IL17lo-hi cells.
Expression of receptors required for migration. iNKT cells
express various chemokine receptors and migrate in response to
chemokines18. However, unlike naı¨ve T cells iNKT cells are rather
sessile and recirculate only modestly17. Therefore, for iNKT cells
the chemokine/receptor-system may be of primordial importance
for processes like intra-organ localization/retention or guiding
iNKT cells freshly released from thymus to peripheral organs39,40.
We ﬁnd that all iNKT subsets express high levels of CXCR6
mRNA (Supplementary Fig. 2a)18. Expression of CXCR3 mRNA
that is up-regulated by TBET41 is biased and high only in iNKT1
cells (Fig. 5a). Virtually all iNKT1 cells express the protein on
their surface (Fig. 5b). This ﬁnding can be exploited to replace
CD122 as a marker to identify iNKT subtypes since identical
subset compositions regarding thymic iNKT cells of BALB/c
or B6 origin were obtained when using either marker
(Supplementary Fig. 2b,c). Also the purity of the CXCR3/CD4-
gated subpopulations is comparable to that using CD122/CD4
(Supplementary Fig. 2d, compare with Fig. 1d). In periphery,
CD122 expression on iNKT1 cells declines, whereas that of
CXCR3 increases. Therefore, it is of advantage to use CXCR3
when classifying iNKT subtypes in periphery (Supplementary
Fig. 2e). CCR7 is detectable only on the surface of approximately
one-third of iNKT2 cells and only very few iNKT1 and iNKT17
cells are CCR7þ (Fig. 5a,b). In addition, CD62L is expressed only
marginally on iNKT2 cells18 that should render homing via HEV
exploiting the classical CCR7/CD62L-based system inefﬁcient.
Instead, peripheral iNKT cells increase expression of CCR7
(Fig. 5c), whereas that of CD62L remains low (Supplementary
Fig. 2f). However, iNKT cells express signiﬁcant levels of mRNA
coding P-selectin ligand (Selplg/PSGL-1, Supplementary Fig. 2g).
By binding to CCL19 and CCL21 PSGL-1 reinforces CCR7
mediated homing of T cells to lymph nodes via HEV obviating
the need of CD62L for this process42. Thus, PSGL-1 could confer
both, iNKT migration into lymph nodes as well as to peripheral
tissue. iNKT17 cells express speciﬁcally CCR6 mRNA as reported
earlier40, but on only a small subpopulation of iNKT17 cells from
BALB/c thymus CCR6 is detectable on the cell surface (Fig. 5a,b).
It was shown that iNKT cells that lack the sphingosine-1-
phosphate receptor 1 (S1P1) develop normally in thymus but
iNKT cell numbers are severely reduced in periphery43.
Therefore, S1P1 expression governs exit of iNKT cells from
thymus as in case of mature naive thymocytes but the block of
emigration is not complete. Surprisingly, the level of S1P1 mRNA
expression in iNKT cells is low particularly when compared with
that of naive CD4þ T cells (Fig. 5d). In BALB/c but not B6
iNKT17 cells the signal reﬂecting S1P1 mRNA expression is
coming close to background levels. This may render emigration of
iNKT17 inefﬁcient providing a potential explanation why
iNKT17 cells are more frequent in BALB/c thymus as
compared with B6 (Supplementary Fig. 2b,c). To test whether
low S1P1 mRNA levels still efﬁciently control exit, we ﬁrst
analyzed recent thymic emigrants (RTE). Indeed, iNKT17 cells
are very rare among iNKT RTE although more frequent in B6
than in BALB/c (Fig. 5e; Supplementary Fig. 4 for B6). However,
there is no simple linear correlation of S1P1 mRNA levels with
emigration rate also because irrespective of the mRNA level,
iNKT2 cells emigrate at considerably higher rates than the other
subsets. This is in agreement with earlier observations
demonstrating that immature iNKT cells preferentially exit
thymus. Unexpectedly however, most of the emigrating iNKT1
cells are CD4þ (Fig. 5f). Treatment of BALB/c mice with
FTY720, a drug that mimics absence of S1P1, before FITC
injection is done, causes a 495% drop in frequency of CD4þ
RTE among splenic lymphocytes demonstrating the effectivity of
drug application (Supplementary Fig. 5a). At the same time, only
very few FITCþ iNKT cells are present in periphery (Fig. 5g;
Supplementary Fig. 5a) conﬁrming that S1P1 expression by all
iNKT cells is mandatory for thymus exit. Surprisingly, FTY720
treatment causes an almost complete disappearance of iNKT2 but
not iNKT1 cells from circulation (Fig. 5g, blood versus spleen,
summary in Supplementary Fig. 5b) indicating a very short dwell
time of iNKT2 cells in blood.
NK-characteristic genes are expressed by iNKT1 cells.
Compared with NK cells there is only a very limited number
of reports investigating the (NK-like) killing capacity of iNKT
cells (for example, refs 44–46). However, in vivo it is difﬁcult to
study direct killing mediated by iNKT cells because of their
capacity to propel the killing activity of NK cells47,48 that was
shown to be mediated by IFNg49 or IL-2 (ref. 48) produced by
activated iNKT cells. We ﬁnd that the bulk of NK signature genes
are expressed by iNKT1 cells (Fig. 6a) conﬁrming the tendency of
increased transcription of these genes when iNKT cell mature
into NK1.1þ cells24. Indeed, the segregation of NK-speciﬁc
transcripts/proteins with iNKT1 but not the other two subsets is
remarkably complete particularly in case of BALB/c (Fig. 6a,b,d;
Supplementary Fig. 6) lending impressive support to the
hypothesis that discrimination of iNKT cells into iNKT1, 2 and
17 cells reﬂects functional differences between these subsets.
However, iNKT1 cells may not represent a uniform population as
reﬂected already by their broadly diverging expression of CD4.
Therefore, we asked whether a disequilibrium exists in expression
between CD4þ iNKT1 and CD4 iNKT1 cells especially
with respect to NK-relevant genes. We sorted BALB/c iNKT1
cells into CD4lo-int and CD4int-hi cells and performed
chip hybridization. Two independent experiments were done
(GEO accession number 69120). NK-marker genes are either
expressed much stronger in CD4 iNKT1 cells or equally well in
CD4þ iNKT1 and CD4 iNKT1 cells (Fig. 6b,c). This latter
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group not only contains genes like Tbx21, Stat4 or Xcl1 but also
encompasses many NK-receptors (Fig. 6c). NK-marker genes
with preferential expression in CD4þ iNKT1 cells are not
detectable. These cells preferentially express genes unrelated so
far to NK-function or even counter-acting it such as CD81 (ref. 50)
or IL-4 (ref. 51). Gzma (granzyme a) and Gzmb (granzyme b)
represent key genes involved in NK-triggered killing, and we
observe their expression primarily in CD4 iNKT1 cells.
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Figure 5 | Expression of chemokine receptors and S1P1 by iNKT subsets. (a,b) Expression of chemokine receptors CXCR3, CCR7 and CCR6, (a) on the
RNA level as depicted in Fig. 1e,f (mean±s.d., n¼ 2) and (b) protein expression detected on the cell surface by antibody staining. Cells were gated as
shown in Fig. 1b. (c) Expression of CCR7 by iNKTcells (DAPIB220 tetþ ) of BALB/c thymus (blue) and spleen (red). Thymic iNKTcells of a CCR7 /
animal served as a control. (d) mRNA levels coding S1P1 as depicted in Fig. 1e,f. Numbers given above bars represent average RU obtained by evaluation of
transcriptome data. For a comparison, data from a different experiment analyzing naı¨ve peripheral CD4þ cells of B6 are also shown (naı¨ve CD4þ ).
(e) BALB/c iNKT subtype composition including all iNKT cells (open bars) or only iNKT RTE (FITCþ , grey bars) in compartments as indicated following a
gating strategy as shown in Supplementary Fig. 2b. Shown are means±s.d. (n¼4). (f) Expression of CD4 by BALB/c FITCþ iNKT1 cells
(DAPIB220 tetþ ) of thymus (upper panel) and spleen (RTE, lower panel). (g) BALB/c mice were gavaged with either PBS (control) or FTY720 and
then FITC was injected into thymus one day later. Around 40 h. after injection the cells were analyzed in the indicated compartments. Gating was done as
shown in Supplementary Fig. 2b. Data are representative of at least 3 (b), 3 (c), 2 (e), 2 (f) and 2 (g) independent experiments. An unpaired two-tailed
Mann–Whitney test was performed in (e); NS, not signiﬁcant (P40.05), *Po0.05.
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When investigating their expression on the protein level in more
detail on iNKT cells sorted into CD4 iNKT1, CD4þ iNKT1,
iNKT2 and iNKT17 cells, respectively, granzyme a is already
detectable in steady state in iNKT1 cells whereas granzyme b is
translated into protein only on stimulation. In both cases,
CD4 iNKT1 cells produce signiﬁcantly more granzymes than
the CD4þ cells. Taken together, these results suggest that a
NK-like phenotype is not restricted to the CD4 iNKT1 cells but
their more pronounced equipment with NK-speciﬁc machinery
may accentuate the NK-character of CD4 iNKT1 cells.
SerpinB1 impacts on iNKT17 cell numbers in thymus and lung.
Our initial studies exploring iNKT cells from BALB/c thymus
revealed many additional genes that exert a biased expression
proﬁle among the iNKT subsets (Supplementary Table 2).
Figure 7 shows a compendium of further genes that display a
subtype-speciﬁc expression pattern. The functional relevance
of these genes for iNKT cell biology was partly
investigated52–56 but the chip analyses performed also reveal
some interesting candidates for further research. Hopx (Fig. 7c)
codes for a transcription cofactor that affects function of
regulatory T cells57 and inﬂuences survival of TH1 cells58. The
serine protease SerpinB1 regulates expansion of IL-17 producing
gdT cells and Th17 cells59. Its strong expression by iNKT17 cells
led us to speculate whether SerpinB1 controls abundance of these
cells. We detected iNKT17 cells from organs of serpinb1a /
mice based on their speciﬁc expression of syndecan-1
(Fig. 7c,d)52. While total frequencies of iNKT cells in thymus,
spleen and lung are not affected in serpinb1a / animals, those
of iNKT17 are increased in all organs tested.
Discussion
Recent studies suggest that the subdivision of iNKT cells into
iNKT1, 2 and 17 cells represents a well-founded platform to
explain many of the variegated immunological activities of these
cells. We investigated this in more detail performing a series of
transcriptome analyses of sorted iNKT subpopulations. We
identify many genes expressed highly speciﬁc in either of the
BALB/c iNKT1, 2 or 17 subsets. This is not only obvious for
NK-related markers expressed by iNKT1 cells but also other
genes of known or hitherto unknown relevance for iNKT cell
development and function. However, the frequently observed
unambiguous correlation of gene expression with iNTK subtype
is on average less pronounced in B6. We assume that this is
caused by the less clean cell sorts because the predominant iNKT1
cell population complicates proper gating. Advanced sorting
strategies making use of alternative markers like CXCR3 or
syndecan-1 will be useful to bypass this problem in future
analyses. Despite of this, the expression pattern of numerous
iNKT-key genes is highly similar between both mouse strains.
The frequency of iNKT cells as well as the composition of the
iNKT cell pool in thymus varies greatly depending on the mouse
strain under scrutiny23,60. iNKT cells are less frequent in B6
thymus with iNKT1 cells predominating whereas in BALB/c
iNKT2 cells prevail but also prominent subpopulations of iNKT1
and iNKT17 cells are present. The genetic background is likely to
play a major role governing the subset composition even though
exogenous factors were also described to contribute61. We found
several genes that are expressed quite differently in B6 versus
BALB/c iNKT cells that may help explain the existing variations
among mouse strains. For example, mRNA for cathepsin L is
strongly expressed in BALB/c but not B6 iNKT cells (Fig. 2).
Mice deﬁcient for cathepsin L almost completely lack iNKT
cells62 and the divergent levels observed in iNKT cells hint to a
potential role of cathepsin L in governing the quantity of iNKT
cells generated in thymus of different mouse strains. A strain
speciﬁc expression is also evident for Hey1 coding for HESR1,
a transcriptional repressor, and Ascl1 (MASH1), a transcriptional
activator. In neuronal cells, expression of HESR1 correlates
with delayed differentiation of progenitors and functionally
antagonizes MASH1 that promotes their differentiation63. It is
possible, that this transcriptional network is also involved in
regulating the dynamics of iNKT cell differentiation making them
promising candidates for future work exploring iNKT cell
development and function.
Expression of functional S1P1 is necessary but not sufﬁcient for
iNKT cells to leave thymus. Among RTE, iNKT2 cells are present
at a disproportionally high frequency although iNKT1 and
iNKT2 cells express similar levels of S1P1 mRNA. Although
additional factors may render iNKT2 cells more competent to
emigrate, it is likely that iNKT1 cells are hampered in emigration
by high levels of CXCR3 expression as already described
earlier64,65. Nevertheless, iNKT1 cells are present among RTE
to a considerable extent. Remarkably however, these iNKT1 cells
were mostly CD4þ indicating that CD4 cells don’t emigrate
efﬁciently. The cause for this remains an open issue since both
subpopulations express comparable amounts of mRNAs coding
for S1P1 and CXCR3. It was demonstrated that iNKT RTE in
juvenile mice rather quickly develop from NK1.1 into NK1.1þ
cells15 and that CD4þ IL-4 iNKT2 cells can differentiate into
CD4þ iNKT1 cells23. Therefore, a distinct proportion of the
iNKT1 RTE may represent cells that emigrate as iNKT2 cells but
convert into iNKT1 cells in periphery (maintaining their CD4
expression). However, this cannot explain the rapid and almost
complete disappearance of iNKT2 cells from blood following
FTY720 administration since the proportion of iNKT2 cells in
spleen remains unchanged. The almost complete clearance from
blood rather indicates that iNKT2 cells can recirculate via
CCR7/PSGL-1 and are trapped inside lymph nodes on FTY720
treatment just as naı¨ve T cells. iNKT cells are rather sessile and
hardly recirculate17,66 but these analyses investigated the total
pool peripheral iNKT cells where iNKT2 cells are much less
frequent than iNKT1 cells. Interestingly, the ‘highest’ exchange
rate for iNKT cells in parabiotic mice occurs in peripheral lymph
node where iNKT2 tend to migrate preferentially supporting the
idea that iNKT2 cells but no other subsets possess a limited
recirculation potential17,60.
Cytotoxic cells can execute killing of targets by either
membrane bound receptor systems such as FasL/Fas or TRAIL/
TRAILR or via soluble components like perforin, granzyme a and
granzyme b. Soluble mediators are expressed preferentially by
CD4 iNKT1 cells whereas some NK-receptors as well as Fas
ligand (fasl) and TRAIL (Tnfsf10) display a much more balanced
expression not co-varying with CD4-levels. Therefore, CD4þ
iNKT1 cells should be able to kill target cells. This is supported by
a recent report suggesting that antigen dependent killing by
iNKT cells is mediated via the FASL/FAS-axis46 and correlates
positively with TCR-signalling strength. If so, this would
handicap the killing capacity of CD4 iNKT1 cells because they
proﬁt much less from beneﬁts of CD4-mediated ampliﬁcation of
the TCR signal than the CD4þ cells29. On the other hand, it was
shown that CD4 iNKT cells isolated from liver are far more
potent in tumour rejection than CD4þ iNKT cells51 and also
express signiﬁcantly more IFNg and granzymes (this report).
Interestingly, the granzymes possess additional functions:
Granzyme a can promote inﬂammation by inducing secretion
of IL-1b, TNFa and IL-6 by cells exposed to it67 and granzyme b
plays a role in remodelling basement membranes of endothelia
supporting efﬁcient transmigration of effector cells to sites of
inﬂammation68. Taken together, this suggests that the two iNKT1
subpopulations perform overlapping but also specialized jobs in
immune surveillance.
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Figure 7 | SerpinB1 deﬁciency impacts on frequency of iNKT17 cells. (a,c) mRNA levels coding for selected genes that are expressed in a iNKT subtype
speciﬁc fashion as depicted in Fig. 1e,f (mean±s.d., n¼ 2). (b) Cell surface expression of Ly6c (left panel), IL-6Ra (middle panel) and IL-1R1 (right panel) on
iNKT1, 2 and 17 cells (DAPIB220 tetþ ) isolated from thymus of BALB/c mice. (d) iNKT17 cells are expanded in frequency in various organs of
Serpinb1a / mice. Left panels show a representative stain of iNKT17 cells (DAPIB220 tetþ ) of various organs of Serpinb1a / or WTmice based on
the expression of syndecan-1 (CD138). Right panels: Each dot represents one animal analyzed (WT: n¼ 6; ko: n¼6). Unpaired two-tailed t-test was done
for thymus, two-tailed Mann–Whitney test for spleen and lung. NS, not signiﬁcant (P40.05), **Po0.01. Data are representative of 2 (b,d) independent
experiments or were pooled from 2 independent experiments (d, right panels).
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Surprisingly, we observed that in BALB/c but also in B6 up to
half of the thymic iNKT17 cells express low levels of IL-4 along
with IL-17. This population escaped detection in earlier studies
probably because iNKT17 cells are much less frequent in B6
thymus. In an attempt to explore differences between IL-17þ
iNKT17 and IL-17þ IL-4þ iNKT17 cells, we failed to detect a
surface receptor that would allow cell sorting of these two
populations. Therefore, we investigated 4get mice where IL-4
expression is coupled to that of GFP due to a knock-in into the
genomic IL-4 locus. However, the GFP-signal detected in thymic
iNKT17 cells of these mice is smeary and cells lacking any
GFP-signal represent a small minority (Supplementary Fig. 2h).
This is consistent with the assumption that IL-17þ IL-4þ iNKT17
cells represent an intermediate commencing ﬁnal differentiation
into single positive IL-17þ iNKT17 cells. This idea suggests
further that developmental precursors of IL-17þ IL-4þ iNKT17
cells originate from the pool of iNKT2 cells. In support of this, we
detect a small but distinct population of cells among iNKT2 cells
that is characterized by an IL-4þ IL-17lo-hi signal. Along with
recent ﬁndings23,27 this places iNKT2 cells in the centre of ﬁnal
differentiation of iNKT17 and iNKT1 cells. In line with this,
prominent fractions of IL-4þ IFNgþ and IL-4þ IL-17þ cells are
only present in the iNKT2 cell pool and at the same time a
substantial population of IL-17þ IFNgþ cell was never detected.
Although the results shown here provide comprehensive
support for the iNKT1/2/17-concept, the in depth characteriza-
tion of iNKT1, 2 and 17 thymocytes reveals that each subset is not
composed of a uniform population of cells. This was already
shown to be the case for iNKT2 cells where IL-4þ cells are clearly
distinct from IL-4 cells. We provided evidence that a
substantial proportion of iNKT17 cells express IL-4 along
with IL-17. It remains to be determined whether IL-4þ IL-17þ
iNKT cells represent a transitory population differentiating
into IL-17þ cells. Our current view would be in line with a
hypothesis merging traditional and new aspects as already
proposed before23,27,69: each iNKT subset contains a population
of terminally matured cells (CD4 iNKT1, IL-4þ iNKT2,
IL-17þ iNKT17) but also a population of cells not yet ﬁnally
differentiated (CD4þ iNKT1 cells, IL-4 iNKT2, IL-4þ IL-17þ
iNKT17).
Methods
Mice. C57BL/6N (B6) and BALB/cAnNCrl (BALB/c) mice were bred in the animal
facility of Hannover Medical School under speciﬁc pathogen-free conditions.
B6.Serpinb1atm1.1Cben mice referred to as serpinB1 / mice throughout the
manuscript, and the corresponding control mice were raised at the University
of Bern. BALB/c.129-Il4tm1Lky mice referred to as 4get mice were raised at the
University of Erlangen, C.129P2(B6)-Fcer1gtm1Rav (FceR1g / ) were purchased
from Taconic Biosciences and the respective control BALB/cByJ animals from
Charles River Laboratories. All animals used in this study were female and were
7–12 weeks old at the time of analysis. All animal experiments were approved by
the LAVES, Lower Saxony, and were conducted according to MHH guidelines.
Lymphocyte isolation from lung and liver. Lungs and Livers were perfused with
cold PBS before harvest. Organs were cut into small pieces and digested with
0.5mgml 1 collagenase D (Roche) and 0.025mgml 1 DNase I (Roche) in RPMI
1640/5% FCS for 45min at 37 C. After digestion EDTA was added to a ﬁnal
concentration of 20mM. Next, samples were mashed trough 40 mm cell strainers
and washed once in RPMI 1640 medium/5% FCS. Samples were layered on Percoll
gradients (40–70%) and centrifuged for 20min at 300g. Following centrifugation,
the interphase containing the enriched lymphocytes was collected.
Flow cytometry. Single-cell suspensions were prepared and blocked with 3% rat
serum in FACS buffer (PBS/3% FCS). All surface stainings were performed for
30min on ice, except for CCR7 which was done for 30min at 37 C. Intracellular
stainings for PLZF and RORgt were done using Foxp3 staining buffer
(eBioscience), according to the protocol provided by the manufacturer. For
intracellular cytokine stainings the ICS staining buffer set (eBioscience) was used.
Antibodies used (clone name; dilution): anti-mCD4 (RM4–5; 1:400), anti-mCD122
(TM-b1; 1:200), anti-mLy6C (HK1.4; 1:400), anti-mIL4 (11B11; 1:100),
anti-mIL6Ra (D7715A7; 1:100), anti-mIL1R (JAMA-147; 1:100), anti-mCCR6
(29–2L17; 1:100), anti-mNKG2D (CX5; 1:200), anti-mIFNg (XMG1.2; 1:100)
and anti-m IL17A (TC11-18H10.1; 1:1,000) all from BioLegend; anti-mCD3e
(145-2C11; 1:100) anti-mPLZF (Mags21F7; 1:100), anti-mRORgt (B2D; 1:400),
anti-mCXCR3 (CXCR3-173; 1:100), anti-mCCR7 (4B12; 1:100), anti-mGzma
(GzA-3G8.5; 1:100), anti-mGzmb (NGZB; 1:100) and anti-mB220 (RA3-6B2;
1:200) were from eBioscience. Anti-mCD94 (18d3; 1:100) and anti-mNKp46
(29A1.4.9; 1:100) were from Miltenyi Biotec, anti-mCD247 (H146-968; 1:100) was
from Molecular Probes and anti-mCD138 (281-2; 1:200) was from BD Pharmin-
gen. CD1d tertramer loaded with PBS57 (analogue of a-galactosylceramide) was
provided by the tetramer facility of US National Institutes of Health and used in a
dilution of 1:1000. Data were acquired on LSR II (Becton and Dickinson) and
analyzed using FlowJo (TreeStar).
In vitro cytokine production. Sorted thymic iNTK cells were plated at a density of
5 105 per ml and incubated at 37 C for 4 h in presence of ionomycin
(1.5 mgml 1), PMA (phorbol 12-myristate 13-acetate; 50 ngml 1) and Brefeldin
A (10 mgml 1) in RPMI 1640/10% FCS. During this step control cells are kept on
ice in FACS buffer. For some experiments, 200ml of sorted iNKT17 cells in RPMI
1640/10% FCS/10 mgml 1 Brefeldin A were seeded into wells that were coated
with 1 mgml 1 anti CD3 antibody (clone 17A2) and 2 mgml 1 anti CD28
antibody (clone 37.51). Cells were incubated for 6 h at 37 C before cytokine
detection by intracellular staining.
Intrathymic FITC injection. Before injection, mice were anaesthetised by an
intra-peritoneal injection of xylazine (9mg per kg body weight) and ketamine
(90mg per kg body weight). Each thymic lobe was injected with 10 ml 500 ngml 1
FITC solution in PBS (Sigma-Aldrich) using a 27G needle. Forty hour
post-injection cells from blood, spleen and mLN were analyzed.
Cell sorting. Single-cell suspensions from single or pooled thymi were prepared,
stained with appropriate Ab and sorted on FACSAria IIu or FACSAria Fusion
(Becton Dickinson). Cell fractions were collected as follows: iNKT (DAPI
B220CD1d-PBS57þ ), iNKT1 (DAPIB220PBS57þCD122þ ), iNKT2
(DAPIB220CD1d-PBS57þCD122CD4þ ) and iNKT17 (DAPIB220
CD1d-PBS57þCD122CD4 ). The purity of sorted cells was routinely 490%.
Isolation of RNA and microarray assay. Tymic iNKT subsets from pooled
5–6 female WT animals were FACS sorted and RNA was isolated using the RNeasy
Plus Micro Kit (Qiagen).
The Microarray study has been performed by use of a reﬁned version of the
Whole Mouse Genome Oligo Microarray 4 44K v2 (Design ID 026655, Agilent
Technologies), called ‘026655AsQuadruplicatesOn4x180K’ (Design ID 048306)
developed in the Research Core Unit Transcriptomics of Hannover Medical School.
Microarrays of this design type cover roughly 32000 murine transcripts.
Microarray design was deﬁned at Agilent’s eArray portal using a 4 180K design
format for mRNA expression as template. All non-control probes of design ID
026655 have been selected to be printed four times onto one 180 K Microarray
(yielding on-chip quadruplicate Features). Control probes required for proper
Feature Extraction software operation were determined and placed automatically
by eArray using recommended default settings.
A total of 6.5 ng RNA were used to prepare aminoallyl-UTP-modiﬁed (aaUTP)
cRNA (Amino Allyl MessageAmp II Kit; #AM1753; LifeTechnologies) as
directed by the company (applying one-round of ampliﬁcation). The labelling of
aaUTP-cRNA was performed by use of Alexa Fluor 555 Reactive Dye (#A32756;
LifeTechnologies). Before the reverse transcription reaction, 1 ml of a 1:100,000
dilution of Agilent’s ‘One-Colour spike-in Kit stock solution’ (#5188–5282,
Agilent Technologies) was added to each total RNA sample.
cRNA fragmentation, hybridization and washing steps were carried-out as
recommended in the ‘One-Colour Microarray-Based Gene Expression Analysis
Protocol V5.7’, except that 300 ng (Exp1) or 130 ng (Exp2) of each ﬂuorescently
labelled cRNA population were used for hybridization.
Slides were scanned on the Agilent MicroArray Scanner G2565CA
(pixel resolution 3 mm, bit depth 20). Data extraction was performed with the
‘Feature Extraction Software V10.7.3.1’ using the extraction protocol ﬁle
‘GE1_107_Sep09.xml’.
Processed intensity values of the green channel, ‘gProcessedSignal’ (gPS) were
normalized by global linear scaling: All gPS values of one sample were multiplied
by an array-speciﬁc scaling factor. This factor was calculated by dividing a
‘reference 75th Percentile value’ (set as 1500 for the whole series) by the 75th
Percentile value of the particular Microarray to be normalized (‘Array I’ in the
formula shown below). Accordingly, normalized gPS values for all samples
(microarray data sets) were calculated by the following formula:
Normalized gPSArray i ¼ gPSArray i x 1;500=75th PercentileArray i
 
Measurements of on-chip replicates (quadruplicates) were averaged using the
geometric mean of normalized gPS values to retrieve one resulting value per probe
and sample. Single Features were excluded from averaging, if they (i) were
manually ﬂagged, (ii) were identiﬁed as Outliers by the Feature Extraction
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13116
12 NATURE COMMUNICATIONS | 7:13116 | DOI: 10.1038/ncomms13116 | www.nature.com/naturecommunications
Software, (iii) lie outside the interval of ‘1.42 interquartile range‘ regarding the
normalized gPS distribution of the respective on-chip replicate population, or, iv)
showed a coefﬁcient of variation of pixel intensities per Feature that exceeded 0.5.
A lower intensity threshold (surrogate value) was deﬁned based on intensity
distribution of negative control features. This value was ﬁxed to 20. All of those
normalized gPS values that fell below this intensity border were substituted by the
respective surrogate value of 20.
Bioinformatics and statistical analysis. The normalized gPS values for selected
genes were used to generate heat maps using Qlucore Omics Explorer software
tool. Prism (GraphPad) software was used for all statistical analysis performed in
the current study. Statistical methods have not been used to predetermine sample
sizes. Where appropriate, data were displayed as mean±s.d. as indicated in the
legends to the ﬁgures, n denotes the number of data points. For all statistical
evaluations a normality test and a variance test were done. Data sets displaying
results from chip hybridizations were excluded from statistical comparisons
because results are of inferior validity when comparisons of two versus two data
points are done. For the statistical evaluations shown in Figs 3c,5e and 7d and
Supplementary Figs 1b,d,2c,4 and 5b three to eight animals per group as given in
the legends were analyzed while allele status was known during analysis. Data were
collected from at least two independent experiments and data obtained from all
animals analyzed are shown. A two-tailed Mann–Whitney U test was done when n
was r4 in one or both of the groups to be compared. For n44 a Kolmogorov–
Smirnov test was done checking for normal or non-normal distribution of the data
points in each group. According to the results of the normality test either unpaired
two-tailed t-test (normal distribution) or two-tailed Mann–Whitney U test
(non-normal distribution) was used as indicated in the legends to the ﬁgures.
Data availability. Transcriptome data that support the ﬁndings of this study have
been deposited in GEO with the primary accession code GSE69120. The authors
declare that all other data supporting the ﬁndings of this study are available within
the article and its Supplementary Information Files.
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